Premium
The clinical and neonatal outcomes after stimulation of immotile spermatozoa using SperMagic medium
Author(s) -
Gu YiFan,
Zhou QinWei,
Zhang ShuoPing,
Lu ChangFu,
Gong Fei,
Shi Yun,
Lu GuangXiu,
Lin Ge
Publication year - 2018
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.13056
Subject(s) - asthenozoospermia , intracytoplasmic sperm injection , andrology , testicular sperm extraction , medicine , miscarriage , sperm , cryopreservation , live birth , gynecology , male infertility , in vitro fertilisation , embryo , biology , infertility , pregnancy , genetics , microbiology and biotechnology
To evaluate the efficiency and safety of SperMagic medium on stimulating the immotile spermatozoa in testicular sperm extraction ( TESE ) and absolute asthenozoospermia, 96 patients with TESE and 106 patients with absolute asthenozoospermia were enrolled in this study. The motile spermatozoa were detected in 47 TESE patients and 68 absolute asthenozoospermia and these patients were assigned to control group. The immotile spermatozoa in 49 TESE patients and 34 absolute asthenozoospermia were stimulated with SperMagic medium. Patients were treated by standard intracytoplasmic sperm injection ( ICSI ). There were no significant differences in fertilisation, cleavage, implantation, pregnancy, live birth and neonatal outcomes. SperMagic medium does not increase incidence of adverse neonatal outcomes and is a reliable tool for selection of viable spermatozoa in ICSI .